Systemic lupus erythematosus (SLE) is still a significant cause of morbidity and increased mortality.
1 However, relevant changes in the spectrum of lupus complications, both in quantitative and qualitative terms, have occurred in the past decades. Survival rates at 5 years, which were below 70% in early series,
2 are currently higher than 90%.
3,4 Active lupus used to be the main cause of death 30 years ago, but today infections and atherothrombosis are also leading determinants of mortality, particularly after a long disease course.
1 Cardiovascular diseases cause not only death but also substantial morbidity.
5,6